HLB bioStep Co.,Ltd. (KOSDAQ: 278650)
South Korea
· Delayed Price · Currency is KRW
2,305.00
-55.00 (-2.33%)
Jan 22, 2025, 3:00 PM KST
HLB bioStep Co.,Ltd. Revenue
HLB bioStep Co.,Ltd. had revenue of 18.54B KRW in the quarter ending September 30, 2024, with 69.33% growth. This brings the company's revenue in the last twelve months to 56.76B, down -9.67% year-over-year. In the year 2023, HLB bioStep Co.,Ltd. had annual revenue of 52.81B, down -38.79%.
Revenue (ttm)
56.76B
Revenue Growth
-9.67%
P/S Ratio
3.43
Revenue / Employee
378.37M
Employees
150
Market Cap
198.70B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |